Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze TRVI stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate TRVI investment potential.

What is TRVI stock price today?

Get real-time TRVI stock price, historical data, and price charts on Financhill. Track TRVI performance with our advanced analysis tools.

Is TRVI a good investment?

Evaluate TRVI investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy TRVI stock?

To buy TRVI stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of TRVI?

View detailed market capitalization data and company valuation metrics for TRVI on our comprehensive analysis page.

What is the P/E ratio of TRVI?

Use our fundamental analysis tools to view TRVI P/E ratio and compare valuation metrics with industry peers.

What are TRVI earnings?

View TRVI earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Trevi Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

TRVI
Trevi Therapeutics, Inc.

Last Price:

$12.83

Seasonality Move:

59.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Trevi Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Trevi Therapeutics, Inc. has on average historically risen by 71.5% based on the past 6 years of stock performance.
Trevi Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Trevi Therapeutics, Inc. Stock Undervalued?

The current Trevi Therapeutics, Inc. [TRVI] share price is $12.85. The Score for TRVI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
TRVI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Trevi Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Trevi Therapeutics, Inc. has on average historically risen by 71.5% based on the past 6 years of stock performance.

Trevi Therapeutics, Inc. Stock Rating

Buy

Trevi Therapeutics, Inc. (TRVI) is a Buy

Is Trevi Therapeutics, Inc. overpriced?

Trevi Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Trevi Therapeutics, Inc. Stock Price History

Is TRVI stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

trevitherapeutics.com

52-Week Data

52-Week High:

14.39

52-Week Low:

3.47

Prediction Charts

Market Cap:

1.6B

Price in USD:

12.85

Volume:

1.2M

Beta:

0.53

Technical Analysis

SMA50:

11.86

SMA100:

10.09

SMA200:

8.26

52-Wk Change:

205.23%

Stock Predictions

Is Trevi Therapeutics, Inc. stock public?

Yes, Trevi Therapeutics, Inc. is a publicly traded company.
What is the Trevi Therapeutics, Inc. stock quote today?

The Trevi Therapeutics, Inc. stock price is 12.85 USD today.
How to buy Trevi Therapeutics, Inc. stock online?

You can buy Trevi Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-8	13.66	12.98	13.66	12.85
Dec-9	13.25	12.99	13.45	12.94
Dec-10	13.07	14.17	14.39	12.92
Dec-11	14.00	13.17	14.16	13.10
Dec-12	13.12	12.77	13.45	12.71
Dec-15	12.88	12.61	13.01	12.49
Dec-16	12.52	12.41	12.93	12.39
Dec-17	12.41	12.11	12.62	11.91
Dec-18	12.25	12.19	12.51	12.02
Dec-19	12.48	13.01	13.22	12.28
Dec-22	12.98	12.74	13.16	12.68
Dec-23	12.64	12.82	13.10	12.50
Dec-24	12.73	12.97	13.19	12.73
Dec-26	12.92	12.85	13.16	12.60

Trevi Therapeutics, Inc. Earnings

Trevi Therapeutics, Inc. Earnings Report: Per Share Trevi Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Trevi Therapeutics, Inc. Forecast Revenue Growth

Trevi Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Trevi Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.10 per share.

* Trevi Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.